Stocks and Investing
Stocks and Investing
Fri, January 6, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Elemer Piros Maintained (ATAI) at Strong Buy with Decreased Target to $15 on, Jan 6th, 2023
Elemer Piros of EF Hutton, Maintained "Atai Life Sciences N.V." (ATAI) at Strong Buy with Decreased Target from $23 to $15 on, Jan 6th, 2023.
Elemer has made no other calls on ATAI in the last 4 months.
There is 1 other peer that has a rating on ATAI. Out of the 1 peers that are also analyzing ATAI, 0 agree with Elemer's Rating of Hold.
This is the rating of the analyst that currently disagrees with Elemer
- Esther Hong of "Loop Capital" Initiated at Strong Buy and Held Target at $18 on, Tuesday, November 1st, 2022
Contributing Sources